Literature DB >> 20687515

Tyrosine 112 is essential for organic cation transport by the plasma membrane monoamine transporter.

Horace T B Ho1, Joanne Wang.   

Abstract

Plasma membrane monoamine transporter (PMAT) is a polyspecific organic cation transporter in the solute carrier 29 (SLC29) family. Previous studies suggested that the major substrate recognition sites are located within transmembrane domains (TM) 1-6, and interaction of PMAT with organic cations may involve aromatic residues. In this study, we analyzed the roles of tyrosine and tryptophan residues located within TM1-6 with a goal of identifying potential residues involved in substrate recognition and translocation. The six tyrosines and one tryptophan in this region were each mutated to alanine followed by analysis of the mutant's membrane localization and transport activity toward 1-methyl-4-phenylpyridinium (MPP(+)), serotonin (5-HT), and dopamine. Two mutants, Y85A and Y112A, exhibited normal cell surface expressions but lost their transport activities toward organic cations. At position Y85, aromatic substitution with phenylalanine or tryptophan fully restored organic cation transport activity. Interestingly, at position Y112, phenylalanine substitution was not allowed. Tryptophan substitution at Y112 partially restored transport activity toward 5-HT and dopamine but severely impaired MPP(+) transport. Detailed kinetic analyses revealed that tryptophan substitution at Y85 and Y112 affected the apparent binding affinity (K(m)) and maximal transport velocity (V(max)) in a substrate-dependent manner. Together, our data suggest that Y85 and Y112 are important molecular determinants for PMAT function, and Y112 is indispensable for optimal interaction with organic cation substrates. Our analyses also suggest the involvement of transmembrane domains 1 and 2 in forming the substrate permeation pathway of PMAT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687515      PMCID: PMC2995015          DOI: 10.1021/bi100560q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

Review 1.  Molecular and cellular physiology of renal organic cation and anion transport.

Authors:  Stephen H Wright; William H Dantzler
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

2.  Hydrophobicity and amphiphilicity in protein structure.

Authors:  D Eisenberg; W Wilcox; A D McLachlan
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

3.  Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.

Authors:  Frank Visser; Mark F Vickers; Amy M L Ng; Stephen A Baldwin; James D Young; Carol E Cass
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

4.  Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation.

Authors:  Sylvia Y M Yao; Amy M L Ng; Mark F Vickers; Manickavasagam Sundaram; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2002-05-02       Impact factor: 5.157

Review 5.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

6.  Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.

Authors:  Li Xia; Mingyan Zhou; Thomas F Kalhorn; Horace T B Ho; Joanne Wang
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08

Review 7.  The SLC22 drug transporter family.

Authors:  Hermann Koepsell; Hitoshi Endou
Journal:  Pflugers Arch       Date:  2003-07-19       Impact factor: 3.657

8.  Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.

Authors:  Christopher J Endres; Dhruba J Sengupta; Jashvant D Unadkat
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

Review 9.  Mammalian nucleoside transporters.

Authors:  Wei Kong; Karen Engel; Joanne Wang
Journal:  Curr Drug Metab       Date:  2004-02       Impact factor: 3.731

10.  Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.

Authors:  Rajgopal Govindarajan; George P H Leung; Mingyan Zhou; Chung-Ming Tse; Joanne Wang; Jashvant D Unadkat
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-22       Impact factor: 4.052

View more
  5 in total

1.  Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter.

Authors:  Horace T B Ho; Yongmei Pan; Zhiyi Cui; Haichuan Duan; Peter W Swaan; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2011-08-04       Impact factor: 4.030

2.  Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse.

Authors:  Yoshiyuki Shirasaka; Nora Lee; Haichuan Duan; Horace Ho; Joanna Pak; Joanne Wang
Journal:  J Chem Neuroanat       Date:  2016-09-15       Impact factor: 3.052

3.  Substituted-cysteine accessibility and cross-linking identify an exofacial cleft in the 7th and 8th helices of the proton-coupled folate transporter (SLC46A1).

Authors:  Srinivas Aluri; Rongbao Zhao; Andras Fiser; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-22       Impact factor: 4.249

Review 4.  The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.

Authors:  J Wang
Journal:  Clin Pharmacol Ther       Date:  2016-09-19       Impact factor: 6.875

5.  Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep.

Authors:  Horace T B Ho; Li Xia; Joanne Wang
Journal:  Biochem Pharmacol       Date:  2012-05-04       Impact factor: 5.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.